Journal Article Summary
The article investigates the prevalence of resistance to two common antiplatelet medications, aspirin and clopidogrel, in patients who have experienced ischemic strokes. This topic is significant because ischemic strokes are a leading cause of death and disability, and understanding how well patients respond to these medications can help tailor treatments to prevent future strokes. Despite the widespread use of these drugs, there is limited data on how many patients do not respond adequately, which could lead to recurrent strokes and other complications.
The study included 158 patients who were taking aspirin, clopidogrel, or both at the time of their stroke. Researchers used specific laboratory tests to measure how effectively these medications inhibited platelet activity. The findings revealed that a notable percentage of patients exhibited resistance: 4% of those with primary strokes and 13% of those with recurrent strokes showed resistance to aspirin, while 30% of primary and 38% of recurrent stroke patients showed resistance to clopidogrel. Additionally, the study highlighted differences in resistance based on sex and ethnicity, with males showing higher resistance to aspirin and females showing higher resistance to clopidogrel.
However, the study has limitations, including a relatively small sample size and a lack of genetic testing for factors that could influence medication response. These limitations mean that the findings may not be applicable to all populations, particularly those with diverse ethnic backgrounds. Patients should discuss these results and their individual responses to antiplatelet medications with their healthcare providers, especially if they have experienced recurrent strokes despite treatment. Understanding one's response to these medications could lead to more personalized and effective treatment strategies.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Cencer Samantha, Packard Laurel, Davis Alan, Ahrar Asad, Miller Malgorzata, Khan Nadeem, Wees Nabil, Min Jiangyong. Prevalence of Aspirin or Clopidogrel Pharmacological Resistance in Ischemic Stroke: A Step Toward Precision Medicine. CNS Neuroscience & Therapeutics 2025. DOI: 10.1111/cns.70343. PMID: 40099828. PMCID: PMC11915341.
Featured Pill Pals Product
1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over --- Generic For Bayer Low Dose --- Time Cap Labs --- Over The Counter
1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over — Generic For Bayer Low Dose — Time Cap Labs — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
